Novel Phosphate Binder Is Effective, Well Tolerated
Chris W. McIntyre, MD, of
Patients took the drug or placebo for three weeks. FMH 1 g three times daily reduced mean serum phosphate from 6.73 mg/dL at baseline to 5.32 mg/dL during treatment. FMH 2 g three times daily resulted in a significant reduction of mean serum phosphate from 6.70 to 4.55 mg/dL. FMH was well tolerated.